News | 16 January 2013
This week, four Biotechnology stocks are improving their overall rating on Portfolio Grader. Each of these rates an ?A? (?strong buy?) or ?B? overall (?buy?). This week, Aegerion Pharmaceuticals (NASDAQ:AEGR) is showing good progress as the company's ...
Click on the link to read the full article at Investorplace.com
(This link will open in a new window)